We are excited to expand and strengthen our commercial leadership team with these outstanding individuals, whose deep knowledge of the neuromodulation business will help continue the momentum and propel us more rapidly toward a broader U.S. launch.
CARLSBAD, Calif. (PRWEB) September 28, 2020
Nalu Medical, Inc. (“Nalu”), a global medical device company that provides miniaturized Neuromodulation implants for the treatment of chronic pain via Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS), today announced the addition of three senior leaders to the commercial organization, including the appointment of Allen Meacham as Chief Business Development Officer.
In this critical role, Mr. Meacham will be responsible for leading, developing and executing Nalu’s sales strategies to drive growth. Mr. Meacham brings with him over 25 years of senior sales leadership and sales training experience, most recently from Boston Scientific, where he spent the last 15 years building and leading their commercial business for the Spinal Cord Stimulator (SCS) and Deep Brain Stimulator (DBS) divisions.
Earl Fender, Nalu’s President and Chief Executive Officer is confident that, “Allen Meacham’s proven track record makes him uniquely positioned to lead Nalu’s commercial efforts to effectively scale our organization and achieve significant growth in the years ahead.”
Additionally, Alan Mock has joined Nalu as Director of Marketing. Mr. Mock is a seasoned leader with more than 30 years of experience in the medical device industry, the last 23 years in the neuromodulation business with Advanced Neuromodulation Systems, St. Jude Medical Neuromodulation and Nuvectra, in various senior sales and marketing leadership roles.
Nalu also welcomes Ron Kuykendall to lead sales training. Mr. Kuykendall is a neuromodulation veteran with over 20 years of sales training, employee coaching & development, sales management and marketing experience with Advanced Neuromodulation Systems, St. Jude Medical Neuromodulation and Nuvectra.
With these key hires, Nalu’s Chief Commercial Officer, Jon Ruais will continue to build the commercial organization while also developing rapid market growth strategies for SCS and PNS in his new role as Chief Commercial and Strategy Officer; his sales responsibilities will shift to Allen Meacham.
“We are excited to expand and strengthen our commercial leadership team with these outstanding individuals, whose deep knowledge of the neuromodulation business will help continue the momentum and propel us more rapidly toward a broader U.S. launch,” said Mr. Fender. “I would also like to recognize and thank Jon Ruais for his outstanding contribution in commercializing the Nalu system and leading our sales efforts these past 12 months.”
About the Nalu Medical
Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options. To learn more, please visit http://www.nalumed.com.
Small size, without compromise.